Compare CCEP & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCEP | IDXX |
|---|---|---|
| Founded | 1986 | 1983 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.0B | 43.6B |
| IPO Year | 2015 | 1996 |
| Metric | CCEP | IDXX |
|---|---|---|
| Price | $106.55 | $561.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | $104.33 | ★ $721.67 |
| AVG Volume (30 Days) | ★ 1.9M | 613.5K |
| Earning Date | 02-17-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.48% | N/A |
| EPS Growth | N/A | ★ 22.59 |
| EPS | N/A | ★ 3.47 |
| Revenue | N/A | ★ $4,303,702,000.00 |
| Revenue This Year | $4.86 | $10.88 |
| Revenue Next Year | $3.79 | $8.59 |
| P/E Ratio | ★ $20.93 | $160.75 |
| Revenue Growth | N/A | ★ 10.42 |
| 52 Week Low | $84.66 | $507.55 |
| 52 Week High | $110.90 | $769.98 |
| Indicator | CCEP | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 73.70 | 53.71 |
| Support Level | $89.82 | $553.20 |
| Resistance Level | $110.90 | $587.04 |
| Average True Range (ATR) | 1.86 | 17.60 |
| MACD | 0.84 | 0.39 |
| Stochastic Oscillator | 87.20 | 79.67 |
CCEP is the second-largest bottling partner in the Coca-Cola system by volume, behind Coca-Cola Femsa, and primarily operates in developed Europe, Australasia, and Southeast Asia. In 2025, CCEP sold 3.9 billion unit cases of beverages, which we estimate equates to roughly 9% of the global Coke system volume.TCCC owns 19% of the equity of CCEP, Olive Partners, a holding company of bottling operations, owns a further 36%, and the remaining 45% is free float.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.